Since these neoplasms have characteristic increases in the number of tumor-infiltrating lymphocytes, their PD-L1 status has fundamental importance in the tumor-agnostic design of their therapeutic approach [124,125,126]. This evidence concerns the gene CD274 and neoplasm.